22245-Lung Cancer-NA-466

Lung Cancer

A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NGM707-IO-101)

  • Details

ClinicalTrials.gov ID: NCT04913337
Diagnosis Type: NA
USOR Number:

  • Address

265 North Broadway
Portland, OR 97227
P: (503) 280-1223

Search by practice name, trial titles, indicators and specific disease types.